Agilent Technologies Inc vs Canadian Natural Resources Ltd. — how do they compare? Agilent Technologies Inc trades at $148.72 (market cap $42.00B), while Canadian Natural Resources Ltd. trades at $47.82 (market cap $97.27B). The key difference: Canadian Natural Resources Ltd. is far larger — about 2.3× Agilent Technologies Inc's market cap, and Canadian Natural Resources Ltd. pays the higher dividend (3.76%). Which is the better fit depends on your goals.
| A | CNQ | |
|---|---|---|
Market Cap | $42.00B | $97.27B |
Sector | Health | Energy |
52-Week High | $157.20 | $50.55 |
52-Week Low | $110.24 | $29.31 |
Enterprise Value | $43.55B | $107.68B |
Dividend Yield | 0.69% | 3.76% |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
Canadian Natural Resources (CNQ) trades at $45.51, up 0.13% with strong technical momentum and bullish moving average signals. The company delivered impressive Q2 2026 results with EPS of $1.53 beating estimates by 7%, driven by record production and operational efficiency. Financials show robust profitability with 22.87% net margin and 26.69% ROE, while valuation remains attractive at 11.35 P/E. Recent news highlights dividend consistency and institutional accumulation.
CNQ presents a compelling investment case with strong fundamentals, consistent earnings beats, and shareholder returns through dividends. Key opportunities include production growth guidance increases and favorable oil pricing exposure. Risks include commodity price volatility and rising capital expenditures. Analyst consensus remains strongly bullish with 75% buy ratings supporting upside potential.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →Canadian Natural Resources is one of the largest oil and natural gas producers in western Canada, supplemented by operations in the North Sea and Offshore Africa. The company's portfolio includes light and medium oil, heavy oil, bitumen, synthetic oil, natural gas liquids, and natural gas. Production averaged 1.16 million barrels of oil equivalent per day in 2020, and the company estimates that it holds over 11.5 billion boe of proven and probable crude oil and natural gas reserves.
Read more on CNQ →